“…For this purpose, we refabricated a two-stream CIJ-D-M and a four-stream MVIM based on the original engineering design by their inventors [9,13]. Curcumin (CUR) was selected as the model drug for the study mainly because it not only has a log P value ($3) typical of most drugs and a well-characterized physicochemical profile, but also displays a wide array of pharmacological activities including anti-inflammatory [16], antioxidant [17], chemopreventive [18], anti-beta-amyloid [19] and anticancer properties [20], all of which are beneficial to the treatment of Alzheimer's disease and various cancers.…”